The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
MEDICARE PART D

PreviousPrevious
Volume 354:2312-2314 June 1, 2006 Number 22
NextNext

The First Months of the Prescription-Drug Benefit — A CMS Update
Peter B. Bach, M.D., M.A.P.P., and Mark B. McClellan, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation

Editor's note: Medicare Part D, designed to provide enhanced prescription-drug coverage for seniors, went into effect in January 2006. Here we present two opposing viewpoints on how successful the implementation of Medicare Part D has been to date and whether it is fulfilling its stated objective.


 
January 1, 2006, marked the beginning of prescription-drug coverage under Medicare.1 The new benefit is provided by competing "stand-alone" private drug plans that work with the traditional fee-for-service Medicare benefit and by plans that are part of private Medicare Advantage programs. After the initial start-up challenges, the drug benefit is being widely used.

Because . . . [Full Text of this Article]


Source Information

Dr. Bach is a senior adviser and Dr. McClellan the administrator of the Centers for Medicare and Medicaid Services, Washington, D.C., and Baltimore.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.